Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Corvus Pharmaceuticals' recent share price puts it on ...

Valentine’s Day is upon us once again, and whether you’re single or happily in love, you might be looking for a good rom-com to watch on Netflix this weekend. The thing is, Netflix has acquired and ...

MOUNTAIN VIEW, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Corvus Robotics, a leader in deploying physical AI robotic systems for logistics and warehousing operations, today announced Corvus One™ for ...

Rewind almost 15 years, and the Android ROM scene was thriving. Nightly builds, tons of projects, we truly were living in a golden age. Nowadays, things have changed significantly. Just what happened ...

Corvus rocketed higher today after it released Phase 1 soquelitinib data for treating eczema, showing excellent patient responses with no serious adverse events. Management plans to move on to a Phase ...

Shares of Corvus Pharmaceuticals rose after its investigational drug soquelitinib showed positive results in an early-stage trial in atopic dermatitis patients. The stock surged 50% to $12.10 in ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Corvus Energy has launched Blue Whale NxtGen, the latest addition to its NxtGen family of batteries designed for vessel applications where high energy content and density are critical. The BW NxtGen ...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2025 Earnings Call Transcript November 4, 2025 Corvus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.14.